Abstract

Research Article

Stability Duration of a Normal Control Pool for Prothrombin Time and Activated Partial Thromboplastin Time Prepared in the Hematology and Blood Bank Service of the Yaoundé University Teaching Hospital, Cameroon

Mokou Claude Bertrand, Juste Patient Mbebi Enone, Toche Fotso Paul Senclaire, Koguep Ngongang Astride, Ngo Etoah Marie Claire, Makuete Lonkeng Alvine, Eyoum Bille Bertrand* and Tayou Tagny Claude

Published: 10 November, 2025 | Volume 9 - Issue 1 | Pages: 027-034

Prothrombin Time (PT), also called Quick’s Time (QT), is a coagulation test expressed in seconds, measured in the presence of tissue thromboplastin and calcium ions. Similarly, Activated Partial Thromboplastin Time (APTT) is measured in the presence of phospholipids, an activator, and calcium ions. These two tests are among the most commonly used in hemostasis. Their execution absolutely requires plasma samples used as quality controls, whether commercial or prepared locally (“pooled” in the laboratory).
This descriptive study aimed to determine the stability duration of an in-house control pool for PT and APTT tests, prepared in the laboratory of the Hematology and Blood Bank service of the Yaoundé University Teaching Hospital, Cameroon.
Plasma was collected after centrifugation, mixed, and then frozen at a temperature of -30 °C to preserve the coagulation factors, especially the most labile ones. The plasma pool was then aliquoted, stored at -30 °C protected from light in a domestic freezer, and kept for a period of two weeks. A portion of the pool was tested within four hours of collection: 30 PT and APTT analyses were performed.
The assay was performed manually using the tube tilt method. The means obtained were 12.71 seconds for PT and 30.66 seconds for APTT. The acceptability limits (mean ± 2 standard deviations), calculated from the standard deviation, were 11.38 to 14.04 seconds for PT and 27.96 to 33.37 seconds for APTT.
The plasma pool was then analyzed daily in duplicate. The average of the results for each day was plotted on a Levey-Jennings chart and interpreted according to Westgard rules. The results showed that the stability duration of the normal control pool is eight (8) days for PT and seven (7) days for APTT.
In a context marked by a recurrent shortage of quality control reagents, for various logistical and economic reasons, these results offer a reliable alternative to commercial control samples, which are often expensive or unavailable. The use of locally prepared control pools could thus compensate for stock-outs of normal or pathological control reagents supplied by manufacturers.

Read Full Article HTML DOI: 10.29328/journal.jhcr.1001038 Cite this Article Read Full Article PDF

Keywords:

Pooled Plasma; Internal quality control; Prothrombin time (Quick’s time); Activated partial thromboplastin time; Stability duration

References

  1. Accreditation Technical Guide. Quality control in medical biology. SH GTA 06, Revision 00. 2012.
  2. Adeniyi T. Evaluation of locally produced plasma control materials for hemostasis assays in sub-Saharan Africa. Afr J Lab Med. 2023;12(1).
  3. Barnet RN. Clinical laboratory statistics. Boston: Little Brown; 1971;70–75.
  4. Bellucci S. Platelet physiology. In: Medical Surgical Encyclopedia, Hematology. Paris: 1991. No. 13000F10.
  5. Implementation of quality control in the clinical biochemistry laboratory. Paris: Éditions Masson, Biochimie Clinique; 1995;75–6.
  6. Bio-Rad Laboratories, Inc. QSD09-098 Q-2004. 2009.
  7. Caen J, Tobelem G. Blood – coagulation. Encyclopædia Universalis [Internet]. 2014 [cited 2025 Jul 27]. Available from: http://www.universalis.fr/encyclopedie/sang-coagulation
  8. Cazivassilio D. Daily health. [Internet]. 2013 [cited 2025 Jul 27]. Available from: https://www.docteurclic.com/specialistes/docteur-denise-cazivassilio-4.asp
  9. Blood and blood cells. Paris: Éditions Nathan; 1996. p. 215.
  10. Clinical and Laboratory Standards Institute (CLSI). H21-A5: Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays. CLSI; 2020.
  11. Cooper G. Basic lessons of laboratory quality control. Bio-Labo; 2009.Available from: https://studylib.net/doc/8251031/basic-lessons-in-laboratory-quality-control
  12. Grosso S. Assessment of lyophilized plasma stability for coagulation testing. Clin Chem Lab Med. 2020;58(11).
  13. Kandemir F. Stability of frozen plasma control materials for PT and APTT testing. J Lab Med. 2023;47(2).
  14. Koh J. Internal quality control performance of in-house coagulation plasma controls. Int J Hematol. 2020;111(5).
  15. Lebeau JP. Daily health. [Internet]. 2010 [cited 2025 Jul 27]. Available from: https://www.docteurclic.com/specialistes/docteur-jean-pierre-lebeau-41.aspx
  16. Lilbey J. Platelet immunology: fundamental and clinical aspects. London: Euro Text; 1991.
  17. Martin A. Quality control. In: Introduction to the medical biochemistry laboratory. Paris: Éditions Ellipses; 1995;18–25.
  18. Mbanya D. Improving laboratory quality systems in Cameroon: the challenge of local QC materials. Pan Afr Med J. 2022;42(55).
  19. Medical Dictionary. 6th ed. BOHAWES; 2011.
  20. Mukwende P. Comparative stability of commercial and locally prepared plasma controls in hemostasis testing. PLoS One. 2024;19(2).
  21. Nyssen M. Statistical quality control of examinations. In: Quality control of laboratory examinations. Journées nationales de biologie; 1971;43–51.
  22. Okafor E. Analytical stability of in-house plasma controls in routine coagulation testing. Afr J Biomed Res. 2021;24(3).
  23. Professional Order of Medical Technologies of Quebec. Avenue H2T 1G2. 2008. Email: [email protected]. Available from: https://www.optmq.org
  24. Revue CAMES – Série A. 2006;4.
  25. Tobelem G. Platelet–vessel wall interactions. Paris: Laboratoire Millot; 1980–1987.
  26. Valdiguie P, de la Farge F, Solera ML. Quality control of results in the clinical biochemistry laboratory. Rev Med Toulouse. 1998.
  27. Westgard JO. Modern quality control: applications of multirule QC in clinical laboratories. Am J Clin Pathol. 2020;153(1).
  28. World Federation of Hemophilia (WFH). Extract published by the WFH. 2010.
  29. World Federation of Hemophilia (WFH). Guidelines for the management of hemophilia. 3rd ed. 2021. Available from: https://www1.wfh.org/publications/files/pdf-1864.pdf
  30. World Health Organization (WHO). Transfusion safety fact sheet. Geneva: WHO; 2007.Available from: https://www.who.int/publications/i/item/WHO-EHT-08.03
  31. World Health Organization (WHO). Fact sheet. 2012. Available from: https://www.who.int/mediacentre/facts/fs204/index.html

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?